Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin after worsening heart failure in type 2 diabetes
2017-003510-16Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) and type 2 diabetes mellitus (T2DM) comparing Sotagliflozin with Placebo (2 arms). Started Mar 2018; status: completed.
02
Drugs
sotagliflozin
03
Conditions
heart failure (HF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-003510-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003510-16.